Savannah, GANCT06557902Now EnrollingIRB Ready

Autism Spectrum Disorder Clinical Trial in Savannah, GA

Access cutting-edge autism spectrum disorder treatment through this clinical trial at a research site in Savannah. Study-provided care at no cost to qualified participants.

Sponsored by Intra-Cellular Therapies, Inc.

Quick Self-Assessment

See if you qualify for this Savannah location

Preparing your pre-screening questions…

Expert Care in Savannah

Access autism spectrum disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related autism spectrum disorder treatment provided free

Apply for This Savannah Location

Check if you qualify for this autism spectrum disorder clinical trial in Savannah, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Savannah

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Savannah site if eligible
  4. 4Begin participation

About This Autism Spectrum Disorder Study in Savannah

Study ITI-007-035 is a Phase 1b, multicenter, open-label study to evaluate the safety, tolerability, and PK of lumateperone for pediatric patients with Autism Spectrum Disorder.

Sponsor: Intra-Cellular Therapies, Inc.

Who Can Participate

Inclusion Criteria

Male or female patients between 5 to less than 13 years of age
Primary clinical diagnosis of ASD with symptoms of irritability
ABC-I subscale score of ≥12 at Screening
CGI-S score of ≥3 at Screening
Body mass index (BMI) greater than the 5th percentile according to age- and gender-specific CDC Clinical Growth Charts (2000) at Screening
Ability to swallow capsules

Exclusion Criteria

Has a primary psychiatric diagnosis other than ASD
Reports suicidal ideation (Type 3, 4 or 5 on the Baseline/Screening version of the C-SSRS) within 6 months prior to Screening, or any suicidal behavior within 2 years prior to Screening, and/or the Investigator assesses the patient to be a safety risk to him/herself or others
Clinically significant abnormality within 2 years of Screening that in the Investigator's opinion may place the patient at risk or interfere with study outcome variables
History of a clinically significant cardiac disorder and/or abnormal screening ECG or a QT interval corrected for heart rate using Fridericia formula (QTcF) \> 460 msec at Screening
Patients with a history of orthostatic hypotension or who have orthostatic hypotension at Screening
Has a history of uncontrolled/disruptive behavior in the past 30 days that, in the Investigator's opinion, would preclude the ability to participate in study procedures

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Savannah?

Yes, this clinical trial (NCT06557902) has an active research site in Savannah, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Autism Spectrum Disorder Treatment Options in Savannah, GA

If you're searching for autism spectrum disorder treatment options in Savannah, GA, this clinical trial (NCT06557902) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Savannah research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autism spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all autism spectrum disorder clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Savannah, GA

See all pulmonary embolism clinical trials recruiting in Savannah — not just this study.

Browse Pulmonary Embolism Trials in Savannah →

Browse More Trials by Condition

Pulmonary Embolism TrialsAutism TrialsUTI TrialsAll Conditions →

Ready to Join in Savannah?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Savannah, GA